{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-371389","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2026-08-27T20:30:17+00:00","discovered_at":"2026-08-27T20:31:01.377891+00:00","generated_at":"2026-08-27T20:31:04.816216+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Quince Therapeutics President Charles Ryan to depart Sept 8, 2026","bullets":["President Charles Ryan's last day of employment is September 8, 2026; departure announced August 23, 2026.","Ryan eligible for severance under Executive Change in Control and Severance Agreement dated September 1, 2023.","Severance terms described in definitive proxy statement filed August 25, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-371389","json":"https://secwatch.observer/filing/0001193125-26-371389.json","markdown":"https://secwatch.observer/filing/0001193125-26-371389.md","text":"https://secwatch.observer/filing/0001193125-26-371389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526371389/0001193125-26-371389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526371389/d124795d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-27T20:31:04.816216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e95b6757cf","claim":"Charles Ryan departed as President at Quince Therapeutics, Inc..","evidence_excerpt":"On August 23, 2026, Quince Therapeutics, Inc. (the “Company”) and Charles Ryan, the Company’s President, determined that Mr. Ryan’s last day of employment will be September 8, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526371389/0001193125-26-371389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"determined"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}